TWD 19.4
(-9.98%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 995 Thousand TWD | -92.88% |
2022 | 13.96 Million TWD | 303.55% |
2021 | 3.46 Million TWD | 2668.8% |
2020 | 125 Thousand TWD | -16.11% |
2019 | 149 Thousand TWD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 5.62 Million TWD | 0.0% |
2024 Q2 | 71 Thousand TWD | -98.74% |
2023 Q2 | 465 Thousand TWD | 2225.0% |
2023 Q4 | - TWD | -100.0% |
2023 Q3 | 510 Thousand TWD | 9.68% |
2023 FY | 995 Thousand TWD | -92.88% |
2023 Q1 | 20 Thousand TWD | -89.64% |
2022 Q4 | 193 Thousand TWD | 0.0% |
2022 FY | 13.96 Million TWD | 303.55% |
2021 FY | 3.46 Million TWD | 2668.8% |
2020 FY | 125 Thousand TWD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -202.432% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 402.54 Million TWD | 99.753% |
Level Biotechnology Inc. | 219.54 Million TWD | 99.547% |
Sagittarius Life Science Corp | 71.47 Million TWD | 98.608% |
NeoCore Technology Co., Ltd. | -9.08 Million TWD | 110.952% |
TaiMed Biologics Inc. | 225.23 Million TWD | 99.558% |
VBI | 16.42 Million TWD | 93.941% |
GeneReach Biotechnology Corp. | 27.58 Million TWD | 96.393% |
Taiwan Advance Bio-Pharmaceutical Inc. | 198.45 Million TWD | 99.499% |
SynCore Biotechnology Co.,Ltd | 521 Thousand TWD | -90.979% |
Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 99.17% |
Visgeneer Inc. | 67.48 Million TWD | 98.526% |
Mycenax Biotech Inc. | -375.19 Million TWD | 100.265% |
Sunmax Biotechnology Co., Ltd. | 1.4 Billion TWD | 99.929% |
G&E Herbal Biotechnology Co., Ltd. | 144.58 Million TWD | 99.312% |
Neith Corporation | 18.01 Million TWD | 94.478% |
Medigen Vaccine Biologics Corporation | 230.22 Million TWD | 99.568% |
TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | 95.625% |
Enimmune corporation | -23.37 Million TWD | 104.257% |
TaiRx, Inc. | 2.43 Million TWD | 59.205% |
CHO Pharma, Inc. | -28.27 Million TWD | 103.519% |
EirGenix Inc. | 236.74 Million TWD | 99.58% |
BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 99.046% |
Sunny Pharmtech Inc. | 285.52 Million TWD | 99.652% |
Lin BioScience, Inc. | -17.92 Million TWD | 105.55% |
BioGend Therapeutics Co., Ltd. | 89.61 Million TWD | 98.89% |
Feng Chi Biotech Corp. | 80.72 Million TWD | 98.767% |
Bio Preventive Medicine Corp. | 1.08 Million TWD | 8.126% |
Lukas Biomedical Inc. | 133.89 Million TWD | 99.257% |
RBC Bioscience Corporation | 72.89 Million TWD | 98.635% |
BiOptic Inc. | 152.74 Million TWD | 99.349% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -1005.556% |
Shine-On BioMedical Co.,Ltd. | 6.66 Million TWD | 85.076% |
Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | 61.95% |
Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 99.845% |
Advagene Biopharma Co., Ltd. | -12 Million TWD | 108.29% |
NaviFUS Corp. | 11.82 Million TWD | 91.587% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 96.77 Million TWD | 98.972% |
Sinew Pharma Inc. | -28.98 Million TWD | 103.433% |
Andros Pharmaceuticals Co.,Ltd | 313 Thousand TWD | -217.891% |
Greenyn Biotechnology Co., Ltd | 392.45 Million TWD | 99.746% |
Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | 97.601% |
AP Biosciences Inc | 32.25 Million TWD | 96.915% |
Medigen Biotechnology Corp. | 617.32 Million TWD | 99.839% |
3D Global Biotech Inc. | 5.27 Million TWD | 81.134% |
Pharmosa Biopharm Inc. | 314.5 Million TWD | 99.684% |
Intech Biopharm Corporation | -163.99 Million TWD | 100.607% |
Oneness Biotech Co., Ltd. | 32.56 Million TWD | 96.944% |
Eusol Biotech Co.,Ltd. | -4.02 Million TWD | 124.696% |
TWi Biotechnology, Inc. | -9.73 Million TWD | 110.217% |
Ever Supreme Bio Technology Co., Ltd | 484.75 Million TWD | 99.795% |
TCI GENE Inc. | 174.61 Million TWD | 99.43% |
MegaPro Biomedical Co., Ltd | -16.6 Million TWD | 105.994% |
Senhwa Biosciences, Inc. | -10.17 Million TWD | 109.781% |
Taiwan Bio Therapeutics Co., Ltd | 76.35 Million TWD | 98.697% |
NatureWise Biotech & Medicals Corporation | 76.96 Million TWD | 98.707% |
PharmaEngine, Inc. | 718.97 Million TWD | 99.862% |
Savior Lifetec Corporation | 220.94 Million TWD | 99.55% |
TaiGen Biopharmaceuticals Holdings Limited | 111.68 Million TWD | 99.109% |
OBI Pharma, Inc. | -73.49 Million TWD | 101.354% |
Meribank Biotech Co., Ltd | 138.87 Million TWD | 99.284% |
Acepodia, Inc. | 16.59 Million TWD | 94.003% |
Caliway Biopharmaceuticals Co., Ltd. | 27.46 Million TWD | 96.378% |